标题
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
作者
关键词
-
出版物
NATURE REVIEWS MICROBIOLOGY
Volume 15, Issue 4, Pages 217-231
出版商
Springer Nature
发表日期
2017-02-27
DOI
10.1038/nrmicro.2016.193
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites
- (2016) Jurgen R. Haanstra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals
- (2016) Johan Veerman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Trypanosoma brucei Parasites Occupy and Functionally Adapt to the Adipose Tissue in Mice
- (2016) Sandra Trindade et al. Cell Host & Microbe
- Defining the targets of antiparasitic compounds
- (2016) Tina S. Skinner-Adams et al. DRUG DISCOVERY TODAY
- Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
- (2016) Nobutaka Kato et al. NATURE
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Possibilities and challenges for developing a successful vaccine for leishmaniasis
- (2016) Saumya Srivastava et al. Parasites & Vectors
- Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasiteLeishmania
- (2016) Élodie Gazanion et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beyond Tsetse – Implications for Research and Control of Human African Trypanosomiasis Epidemics
- (2016) Susan C. Welburn et al. TRENDS IN PARASITOLOGY
- Trypanosoma brucei DHFR-TS Revisited: Characterisation of a Bifunctional and Highly Unstable Recombinant Dihydrofolate Reductase-Thymidylate Synthase
- (2016) Marc W. Gibson et al. PLoS Neglected Tropical Diseases
- Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
- (2016) Susan Wyllie et al. PLoS Pathogens
- Pentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2
- (2016) Jie Song et al. PLoS Pathogens
- The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- (2016) Stephen Patterson et al. eLife
- The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes
- (2016) Paul Capewell et al. eLife
- Identification of “Preferred” Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?
- (2016) Emanuele Amata et al. ACS Infectious Diseases
- Drug resistance in eukaryotic microorganisms
- (2016) Alan H. Fairlamb et al. Nature Microbiology
- Autoimmune Pathogenesis of Chagas Heart Disease
- (2015) Kevin M. Bonney et al. AMERICAN JOURNAL OF PATHOLOGY
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Localization of serum resistance-associated protein inTrypanosoma brucei rhodesienseand transgenicTrypanosoma brucei brucei
- (2015) Jean-Mathieu Bart et al. CELLULAR MICROBIOLOGY
- First efficient CRISPR-Cas9-mediated genome editing inLeishmaniaparasites
- (2015) Lauriane Sollelis et al. CELLULAR MICROBIOLOGY
- Nitroheterocyclic drug resistance mechanisms inTrypanosoma brucei
- (2015) Susan Wyllie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ENTH and ANTH domain proteins participate in AP2-independent clathrin-mediated endocytosis
- (2015) P. T. Manna et al. JOURNAL OF CELL SCIENCE
- Architecture of a Host–Parasite Interface: Complex Targeting Mechanisms Revealed Through Proteomics
- (2015) Catarina Gadelha et al. MOLECULAR & CELLULAR PROTEOMICS
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- Chagas’ Disease
- (2015) Caryn Bern NEW ENGLAND JOURNAL OF MEDICINE
- The Social Life of African Trypanosomes
- (2015) Simon Imhof et al. TRENDS IN PARASITOLOGY
- CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment
- (2015) Noelia Lander et al. mBio
- Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome
- (2015) Danae Schulz et al. PLOS BIOLOGY
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- (2015) Jennifer Riley et al. PLoS Neglected Tropical Diseases
- Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome
- (2015) Deuan C. Jones et al. PLoS Neglected Tropical Diseases
- Targeting Lysine Deacetylases (KDACs) in Parasites
- (2015) Qi Wang et al. PLoS Neglected Tropical Diseases
- Genome and Phylogenetic Analyses of Trypanosoma evansi Reveal Extensive Similarity to T. brucei and Multiple Independent Origins for Dyskinetoplasty
- (2015) Jason Carnes et al. PLoS Neglected Tropical Diseases
- Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity
- (2015) Andrea Nühs et al. PLoS Neglected Tropical Diseases
- Modulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes
- (2015) Martin Zoltner et al. PLoS Pathogens
- The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
- (2015) Daniel N. A. Tagoe et al. Frontiers in Pharmacology
- Experimental Vaccines against Chagas Disease: A Journey through History
- (2015) Olivia Rodríguez-Morales et al. Journal of Immunology Research
- Drug Target Identification Using a Trypanosome Overexpression Library
- (2014) Daniela Begolo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
- (2014) Maria T. Bahia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Unconventional Kinetochores in Kinetoplastids
- (2014) Bungo Akiyoshi et al. CELL
- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Fruitful Decade for Antileishmanial Compounds from 2002 to Late 2011
- (2014) Hidayat Hussain et al. CHEMICAL REVIEWS
- Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
- (2014) Advait S. Nagle et al. CHEMICAL REVIEWS
- Genetic Validation of Aminoacyl-tRNA Synthetases as Drug Targets in Trypanosoma brucei
- (2014) Savitha Kalidas et al. EUKARYOTIC CELL
- Infectious diseases in North Africa and North African immigrants to Europe
- (2014) M. Khyatti et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis
- (2014) H. Burrell-Saward et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis
- (2014) Suman Gupta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification and Functional Characterization of a Highly DivergentN-Acetylglucosaminyltransferase I (TbGnTI) inTrypanosoma brucei
- (2014) Manuela Damerow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Design and Synthesis of Potent and Selective Inhibitors of Trypanosoma brucei Glycogen Synthase Kinase 3 for the Treatment of Human African Trypanosomiasis
- (2014) Robert Urich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma brucei N-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis
- (2014) Stephen Brand et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Horizons for Old Drugs and Drug Leads
- (2014) Gordon M. Cragg et al. JOURNAL OF NATURAL PRODUCTS
- Chagas Disease Cardiomyopathy: Immunopathology and Genetics
- (2014) Edecio Cunha-Neto et al. MEDIATORS OF INFLAMMATION
- Networks of gene expression regulation in Trypanosoma brucei
- (2014) C.E. Clayton MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Motility and more: the flagellum of Trypanosoma brucei
- (2014) Gerasimos Langousis et al. NATURE REVIEWS MICROBIOLOGY
- Determinants of disease phenotype in trypanosomatid parasites
- (2014) Laura-Isobel McCall et al. TRENDS IN PARASITOLOGY
- Identification and Characterization of Hundreds of Potent and Selective Inhibitors of Trypanosoma brucei Growth from a Kinase-Targeted Library Screening Campaign
- (2014) Rosario Diaz et al. PLoS Neglected Tropical Diseases
- Regulators of Trypanosoma brucei Cell Cycle Progression and Differentiation Identified Using a Kinome-Wide RNAi Screen
- (2014) Nathaniel G. Jones et al. PLoS Pathogens
- Antiparasitic Chemotherapy: From Genomes to Mechanisms
- (2013) David Horn et al. Annual Review of Pharmacology and Toxicology
- Cyclic AMP Effectors in African Trypanosomes Revealed by Genome-Scale RNA Interference Library Screening for Resistance to the Phosphodiesterase Inhibitor CpdA
- (2013) Matthew K. Gould et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
- (2013) Manu De Rycker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
- (2013) Jonathan W Choy et al. Beilstein Journal of Organic Chemistry
- From On-Target to Off-Target Activity: Identification and Optimisation ofTrypanosoma bruceiGSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma bruceiDrug Discovery Lead Molecules
- (2013) Andrew Woodland et al. ChemMedChem
- Trypanosomatidae Diseases: From the Current Therapy to the Efficacious Role of Trypanothione Reductase in Drug Discovery
- (2013) L.S.C. Bernardes et al. CURRENT MEDICINAL CHEMISTRY
- Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
- (2013) Guangxu Jin et al. DRUG DISCOVERY TODAY
- New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
- (2013) J. M. Bustamante et al. JOURNAL OF INFECTIOUS DISEASES
- Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches
- (2013) Ian H. Gilbert JOURNAL OF MEDICINAL CHEMISTRY
- Adaptin evolution in kinetoplastids and emergence of the variant surface glycoprotein coat in African trypanosomatids
- (2013) Paul T. Manna et al. MOLECULAR PHYLOGENETICS AND EVOLUTION
- High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome
- (2013) Yaser Hashem et al. NATURE
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei
- (2013) Binny M. Mony et al. NATURE
- Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
- (2013) P.M. Loiseau et al. Parasite
- Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
- (2013) IAN H. GILBERT PARASITOLOGY
- Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections
- (2013) ROB DON et al. PARASITOLOGY
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- Proteomic Analysis of Clathrin Interactions in Trypanosomes Reveals Dynamic Evolution of Endocytosis
- (2013) Vincent O. Adung'a et al. TRAFFIC
- Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase
- (2013) Kyle R. Brimacombe et al. ACS Medicinal Chemistry Letters
- In Vivo Imaging of Trypanosome-Brain Interactions and Development of a Rapid Screening Test for Drugs against CNS Stage Trypanosomiasis
- (2013) Elmarie Myburgh et al. PLoS Neglected Tropical Diseases
- Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase
- (2013) Alex P. McLatchie et al. PLoS Neglected Tropical Diseases
- Chemical Proteomic Analysis Reveals the Drugability of the Kinome of Trypanosoma brucei
- (2012) Michael D. Urbaniak et al. ACS Chemical Biology
- Management of trypanosomiasis and leishmaniasis
- (2012) M. P. Barrett et al. BRITISH MEDICAL BULLETIN
- Predictive methods in drug repurposing: gold mine or just a bigger haystack?
- (2012) David Cavalla DRUG DISCOVERY TODAY
- Chemistry-based functional proteomics for drug target deconvolution
- (2012) Kui Wang et al. Expert Review of Proteomics
- Pharmacological Validation of Trypanosoma brucei Phosphodiesterases as Novel Drug Targets
- (2012) Harry P. de Koning et al. JOURNAL OF INFECTIOUS DISEASES
- Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)
- (2012) D. Tweats et al. MUTAGENESIS
- Adenylate Cyclases of Trypanosoma brucei Inhibit the Innate Immune Response of the Host
- (2012) D. Salmon et al. SCIENCE
- The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
- (2012) S. Wyllie et al. Science Translational Medicine
- Leishmaniasis: Current status of available drugs and new potential drug targets
- (2012) Nisha Singh et al. Asian Pacific Journal of Tropical Medicine
- A Static-Cidal Assay for Trypanosoma brucei to Aid Hit Prioritisation for Progression into Drug Discovery Programmes
- (2012) Manu De Rycker et al. PLoS Neglected Tropical Diseases
- Fexinidazole: A Potential New Drug Candidate for Chagas Disease
- (2012) Maria Terezinha Bahia et al. PLoS Neglected Tropical Diseases
- Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India
- (2011) Shyam Sundar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Selective Inhibitors of Methionyl-tRNA Synthetase Have Potent Activity against Trypanosoma brucei Infection in Mice
- (2011) Sayaka Shibata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
- (2011) Daniel Spinks et al. ChemMedChem
- Finding New Hits in Neglected Disease Projects: Target or Phenotypic Based Screening?
- (2011) Ian H. Gilbert et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Target Validation: Linking Target and Chemical Properties to Desired Product Profile
- (2011) Paul G. Wyatt et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Methodological advances in drug discovery for Chagas disease
- (2011) Juan M Bustamante et al. Expert Opinion on Drug Discovery
- Strategies to optimize the brain availability of central nervous system drug candidates
- (2011) Travis T Wager et al. Expert Opinion on Drug Discovery
- Drug repositioning in the treatment of malaria and TB
- (2011) Alexis Nzila et al. Future Medicinal Chemistry
- Development of novel drugs for human African trypanosomiasis
- (2011) Reto Brun et al. Future Microbiology
- High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome
- (2011) S. Alsford et al. GENOME RESEARCH
- Vaccination against trypanosomiasis
- (2011) Florencia La Greca et al. Human vaccines & immunotherapeutics
- The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
- (2011) Bianca Zingales et al. INFECTION GENETICS AND EVOLUTION
- Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
- (2011) Stephen Patterson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
- (2011) Stephen Brand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metabolomic analysis of trypanosomatid protozoa
- (2011) Darren J. Creek et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
- (2011) S. Meister et al. SCIENCE
- 2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach
- (2011) Luke Mercer et al. PLoS Neglected Tropical Diseases
- SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
- (2011) Robert T. Jacobs et al. PLoS Neglected Tropical Diseases
- Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes
- (2010) Travis T. Wager et al. ACS Chemical Neuroscience
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
- (2010) Travis T. Wager et al. ACS Chemical Neuroscience
- Metabolic Pathways Required for the Intracellular Survival of Leishmania
- (2010) Malcolm J. McConville et al. Annual Review of Microbiology
- Probing the Probes: Fitness Factors For Small Molecule Tools
- (2010) Paul Workman et al. CHEMISTRY & BIOLOGY
- The Pre-mRNA Splicing Machinery of Trypanosomes: Complex or Simplified?
- (2010) Arthur Günzl EUKARYOTIC CELL
- Mechanism of interaction of sitamaquine with Leishmania donovani
- (2010) E. S. Coimbra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nuclear DBF-2-related Kinases Are Essential Regulators of Cytokinesis in Bloodstream StageTrypanosoma brucei
- (2010) Jiangtao Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vitro and in vivo experimental models for drug screening and development for Chagas disease
- (2010) Alvaro José Romanha et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Trypanosoma brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice
- (2010) Natasha Sienkiewicz et al. MOLECULAR MICROBIOLOGY
- Chagas disease: pushing through the pipeline
- (2010) Julie Clayton NATURE
- N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
- (2010) Julie A. Frearson et al. NATURE
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
- (2010) Adriana M. C. Canavaci et al. PLoS Neglected Tropical Diseases
- Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
- (2010) Els Torreele et al. PLoS Neglected Tropical Diseases
- Chagas disease in Spain, the United States and other non-endemic countries
- (2009) Joaquim Gascon et al. ACTA TROPICA
- Distinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases
- (2009) Luis Izquierdo et al. EMBO JOURNAL
- Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei
- (2009) T. N. Siegel et al. GENES & DEVELOPMENT
- Chemical Validation of Trypanothione Synthetase
- (2009) Leah S. Torrie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
- (2009) Gerardo Priotto et al. LANCET
- Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase inTrypanosoma bruceiusing chemical and genetic methods
- (2009) Susan Wyllie et al. MOLECULAR MICROBIOLOGY
- Murine Models for Trypanosoma brucei gambiense Disease Progression—From Silent to Chronic Infections and Early Brain Tropism
- (2009) Christiane Giroud et al. PLoS Neglected Tropical Diseases
- Two essential MYST-family proteins display distinct roles in histone H4K10 acetylation and telomeric silencing in trypanosomes
- (2008) Taemi Kawahara et al. MOLECULAR MICROBIOLOGY
- Chemical and genetic validation of dihydrofolate reductase–thymidylate synthase as a drug target in African trypanosomes
- (2008) Natasha Sienkiewicz et al. MOLECULAR MICROBIOLOGY
- Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
- (2007) Ruth Brenk et al. ChemMedChem
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More